The Aurora Study

Currently Recruiting

$3,451

Minneapolis, United States

We’re currently inviting healthy post menopausal women to take part in a clinical study evaluating a potential new treatment for Vulvovaginal Atrophy (VVA). 

Vulvovaginal Atrophy (VVA) is a serious medical condition that affects over 32 million postmenopausal women in the US. Only 7% of those suffering are being treated due to limitations of currently available products. More than 3.5 million breast cancer survivors have no safe therapy available.  

Many women attribute VVA menopause symptoms to an unavoidable natural aging process that they need to just “live with”. They are uncomfortable discussing these symptoms and are not active in seeking help. 

Women must be postmenopausal or bilaterally oophorectomized (removal of both ovaries). 

Apply now Speak with us 612-315-6490

Join our clinical trial

The study is looking for post-menopausal women who have vaginal dryness or painful intercourse. 

  • Self-administered at home dosing
  • Inserted intravaginally
Join our clinical trial image

Why participate?

Many women do not seek treatment for VVA due to stigma, discomfort discussing symptoms, or limited therapeutic options—particularly those who cannot use hormone-based therapies. This study aims to help address that unmet need and advance new options for women’s intimate health. 

  • You’ll be fully informed about all aspects of the trial before consenting to participate. 
  • You’ll receive compensation in consideration of your time and effort. 
  • You’ll have complimentary access to high-speed internet, enabling you to work, study, or stay connected 

Trial details

Participants:

  • Healthy postmenopausal women
  • Age: 45-60
  • BMI: 18-34 kg/m2

Study requirements:

  • Experiencing bothersome symptoms such as painful intercourse, vaginal dryness, or vaginal irritation
  • Self-administered at home dosing

Commitment:

  •  2 inpatient stays each 1 night / 2 days 
  • 1 screen appointment 
  • Up to 2 outpatient visit 

Remuneration:

  • Up to $3451 for study participation time and effort
  • *NEW* We are now offering a $750 referral bonus for each eligible women referred to the Aurora Study who successfully doses.

Schedule a call:

Schedule a call

Are you a match?

Age

45 - 60 years old

Remuneration

$3,451 *with screening reimbursement.
Full details outlined in consent form.

Gender

Female

BMI

BMI 18 - 34 kg/m2

Clinical Research for Post‑Menopausal Women at Nucleus Network

Many of today’s treatments exist because people like you chose to join clinical trials. Taking part is completely your choice—and a meaningful way to support better care for women after menopause.


What to expect:

  • Clear, thorough information before you decide to participate
  • A comfortable clinic setting with a recreation room and high‑speed internet
  • $400–$600 per day for your time and participation
  • Visits at Nucleus Network’s specialized clinic in the Minneapolis–St. Paul area

All visits occur at Nucleus Network’s specialized clinic located in the heart of the Minneapolis-St. Paul metropolitan area.  


Answer a few questions to see if you might be eligible:

Step 1 of 3

Contact information




If you don't have a middle name please leave blank.

Please make sure there is no space at the end of your email address, as this will lead to an error message.

Please start your number with 1, and only use numbers.
The phone number you have entered does not appear to be a valid US phone number. Please check your details and enter a valid phone number starting with country code 1.

The stays will occur during the week and will not be on consecutive nights.
STEP 2 OF 3

This refers to the sex that you were assigned at birth, not your gender identity.

In this study, you will be regularly tested for alcohol and drug use.

We regularly have studies that allow participants who are social smokers.


Please only select 'Yes' if you have used recreational drugs in the last month.

What is your date of birth?

Month Day Year

You need to be at least 18 years old to participate in clinical trials.





lbs



Step 3 of 3

Medical history



At least 12 months without menses or 6 months post bilateral oophorectomy

  • Using a condom + your female partner(s) using a separate form of birth control.
  • You or your partner(s) had a vasectomy/hysterectomy
  • Your partner(s) are post-menopausal
  • Abstinence from heterosexual sex for at least 1 month prior to screen and throughout study


  • Use a condom during sexual intercourse with a male partner during the study and for 1 month after the last dose.











If you select 'Yes' we will ask for your mailing address. None of the data collected from you will be disclosed to other organizations without your prior agreement.
Mailing Address




5 numbers only

By checking Yes - you will receive marketing text messages regarding upcoming studies at NN.


By completing this form you express your interest in participating in a clinical trial of new medication. We will contact you to follow up on your eligibility to participate.


Before your potential participation you will speak with our Recruitment and Medical teams who will answer all of your questions.

By registering your interest, you are consenting to receive communications about studies that could be a good fit for you. You can unsubscribe at any time. View our privacy policy for more information.